2,281
Views
33
CrossRef citations to date
0
Altmetric
Research Paper

NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway

, , , , , , , & show all
Pages 943-954 | Received 02 Mar 2016, Accepted 03 Jul 2016, Published online: 22 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (32)

Qian Cheng, Shanglei Ning, Lei Zhu, Changlu Zhang, Shaodong Jiang, Yajing Hao & Jiye Zhu. (2023) NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination. British Journal of Cancer 129:2, pages 237-248.
Crossref
Soudeh Ghafouri-Fard, Sara Ahmadi Teshnizi, Bashdar Mahmud Hussen, Mohammad Taheri & Guive Sharifi. (2023) A review on the role of NDRG1 in different cancers. Molecular Biology Reports 50:7, pages 6251-6264.
Crossref
Xin Wang, Xiaodong Gu, Cheng Wang, Yingzi He, Dong Liu, Shan Sun & Huawei Li. (2023) Loss of ndrg2 Function Is Involved in Notch Activation in Neuromast Hair Cell Regeneration in Zebrafish. Molecular Neurobiology 60:6, pages 3100-3112.
Crossref
Stuti Khadka, Sara R. Druffner, Benjamin C. Duncan & Jonathan T. Busada. (2023) Glucocorticoid regulation of cancer development and progression. Frontiers in Endocrinology 14.
Crossref
Liping Ren, Xianrun Pan, Lin Ning, Di Gong, Jian Huang, Kejun Deng, Lei Xie & Yang Zhang. (2023) Construction of a Combined Hypoxia-related Genes Model for Hepatocellular Carcinoma Prognosis. Current Computer-Aided Drug Design 19:2, pages 150-161.
Crossref
Jing Guo, Qiuxing Yang, Sheng Wei, Jingjing Shao, Tianye Zhao, Liyuan Guo, Jia Liu, Jia Chen & Gaoren Wang. (2022) Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. BMC Cancer 22:1.
Crossref
Vaibhavi Joshi, Sunil R. Lakhani & Amy E. McCart Reed. (2022) NDRG1 in Cancer: A Suppressor, Promoter, or Both?. Cancers 14:23, pages 5739.
Crossref
Guo-Rung You, Joseph T. Chang, Hsiao-Fan Li & Ann-Joy Cheng. (2022) Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif. Cells 11:9, pages 1581.
Crossref
Rebecca Davies, Ling Liu, Sheng Taotao, Natasha Tuano, Richa Chaturvedi, Kie Kyon Huang, Catherine Itman, Amit Mandoli, Aditi Qamra, Changyuan Hu, David Powell, Roger J. Daly, Patrick Tan & Joseph Rosenbluh. (2021) CRISPRi enables isoform-specific loss-of-function screens and identification of gastric cancer-specific isoform dependencies. Genome Biology 22:1.
Crossref
Tong Zhao, Ying Meng, Yongping Wang & Wenji Wang. (2021) NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Sarah L. Bevington, Remi Fiancette, Dominika W. Gajdasik, Peter Keane, Jake K. Soley, Claire M. Willis, Daniel J. L. Coleman, David R. Withers & Peter N. Cockerill. (2021) Stable Epigenetic Programming of Effector and Central Memory CD4 T Cells Occurs Within 7 Days of Antigen Exposure In Vivo. Frontiers in Immunology 12.
Crossref
Koji Yamanoi & Masaki Mandai. 2021. Molecular Diagnosis and Targeting for Gynecologic Malignancy. Molecular Diagnosis and Targeting for Gynecologic Malignancy 79 94 .
Shunsuke Ueki, Fumiyoshi Fujishima, Takuro Kumagai, Hirotaka Ishida, Hiroshi Okamoto, Kai Takaya, Chiaki Sato, Yusuke Taniyma, Takashi Kamei & Hironobu Sasano. (2020) GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy. BMC Cancer 20:1.
Crossref
Kyung Chan Park, Jasmina Paluncic, Zaklina Kovacevic & Des R. Richardson. (2020) Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radical Biology and Medicine 157, pages 154-175.
Crossref
Wei Zhou, Kang Huang, Qiuyan Zhang, Shaojun Ye, Zibiao Zhong, Cheng Zeng, Guizhu Peng, Ling Li & Qifa Ye. (2020) LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression. PeerJ 8, pages e8394.
Crossref
Guobo Du, Jing Zhou, Long Cheng, Xiaojie Ma, Yan Gui & Bangxian Tan. (2020) High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer. Combinatorial Chemistry & High Throughput Screening 22:9, pages 599-611.
Crossref
Sen Zhang, Chaoran Yu, Xiao Yang, Hiju Hong, Jiaoyang Lu, Wenjun Hu, Xiaohui Hao, Shuchun Li, Batuer Aikemu, Guang Yang, Zirui He, Luyang Zhang, Pei Xue, Zhenghao Cai, Junjun Ma, Lu Zang, Bo Feng, Fei Yuan, Jing Sun & Minhua Zheng. (2019) N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Sheng Wu, Katja Nitschke, Jakob Heinkele, Cleo-Aron Weis, Thomas Stefan Worst, Markus Eckstein, Stefan Porubsky & Philipp Erben. (2019) ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data. Cancers 11:12, pages 1840.
Crossref
Simone L. Schonkeren, Maartje Massen, Raisa van der Horst, Alexander Koch, Nathalie Vaes & Veerle Melotte. (2019) Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system. neurogenetics 20:4, pages 173-186.
Crossref
An-Yue Wu, Yuan Hu, Wei Cang, Dong Li, Wen-Jing Wang, Qi Tian, Li-Ying Gu, Ning Zhang, Fang Ji & Li-Hua Qiu. (2019) Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis. Experimental Cell Research 382:2, pages 111468.
Crossref
Ryan A. Denu, Madilyn M. Sass, James M. Johnson, Gregory K. Potts, Alka Choudhary, Joshua J. Coon & Mark E. Burkard. (2019) Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131). Journal of Biological Chemistry 294:16, pages 6531-6549.
Crossref
Aiwei Li, Xi Zhu, Chanjuan Wang, Shuo Yang, Yan Qiao, Rui Qiao & Jie Zhang. (2019) Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer. Scientific Reports 9:1.
Crossref
Ji-sheng Jing, Hongbo Li, Shun-cai Wang, Jiu-ming Ma, La-qing Yu & Hua Zhou. (2018) NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma. Bioscience Reports 38:6.
Crossref
Li Li, Xiaoxia Dong, Feng Peng & Li Shen. (2018) Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147. Cancer Cell International 18:1.
Crossref
Kang Chen, Xiao-Hong Liu, Fu-Rong Wang, Hai-Peng Liu, Ze-Ping Huang & Xiao Chen. (2018) The prognostic value of decreased NDRG1 expression in patients with digestive system cancers. Medicine 97:41, pages e12455.
Crossref
Chun-Chi Chang, Ya-Sian Chang, Hsi-Yuan Huang, Kun-Tu Yeh, Ta-Chih Liu & Jan-Gowth Chang. (2018) Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing. Human Pathology 78, pages 151-158.
Crossref
Bo Qi, Yan Wang, Zhi-Jun Chen, Xiang-Nan Li, Yu Qi, Yang Yang, Guang-Hui Cui, Hai-Zhou Guo, Wei-Hao Li & Song Zhao. (2017) Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway. World Journal of Gastroenterology 23:45, pages 7965-7977.
Crossref
Sharleen V. Menezes, Sumit Sahni, Zaklina Kovacevic & Des R. Richardson. (2017) Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling. Journal of Biological Chemistry 292:31, pages 12772-12782.
Crossref
Xiaoping Liu, Yanli Yan, Weiping Ma & Suge Wu. (2017) Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Biochemical and Biophysical Research Communications 490:3, pages 1112-1118.
Crossref
Ning Zhang, Baoan Hong, Wenyong Lian, Changhua Zhou, Siqi Chen, Xin Du, Xiaohu Deng, Shayiremu Duoerkun, Qing Li, Yong Yang & Kan Gong. (2017) Vascular endothelial growth inhibitor 174 and its functional domains inhibit epithelial-mesenchymal transition in renal cell carcinoma cells in�vitro. International Journal of Molecular Medicine.
Crossref
Yanhui Liu, Qun Zhou, Dexi Zhou, Cheng Huang, Xiaoming Meng & Jun Li. (2017) Secreted frizzled-related protein 2-mediated cancer events: Friend or foe?. Pharmacological Reports 69:3, pages 403-408.
Crossref
Yi Qin, Yi Zhang, Qinting Tang, Li Jin & Yong'an Chen. (2017) SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma. Acta Biochimica et Biophysica Sinica 49:2, pages 138-148.
Crossref